MedPath

A study comparing Levetiracetam and Valproic Acid in preventing seizure in children diagnosed with neurocystcercosis.

Not Applicable
Completed
Conditions
Health Condition 1: G060- Intracranial abscess and granuloma
Registration Number
CTRI/2019/01/017368
Lead Sponsor
Dr Abhinav Aggarwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

All children diagnosed with Neurocysticercosis aged 5 to 18 years presenting with focal Seizure/GTCS episode

Exclusion Criteria

Previous treatment with anti epileptic drugs prior to visiting the hospital

Seizures due to meningitis, major congenital anomaly, metabolic causes and febrile seizure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath